Better diagnosis of borderline and invasive IPMNs and MCNs would be highly significant, and enable patients to choose the most appropriate course of action; this 5-gene PDAC classifier may provide such a risk assessment.
← all excerpts
Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.
1
—
—